Lv5
1566 积分 2024-10-31 加入
Recent advances in drug treatment for prostate cancer
11小时前
已完结
CDK2 heterobifunctional degraders co-degrade CDK2 and cyclin E resulting in efficacy in CCNE1-amplified and overexpressed cancers
12天前
已完结
CDK2 heterobifunctional degraders co-degrade CDK2 and cyclin E resulting in efficacy in CCNE1-amplified and overexpressed cancers
12天前
已完结
Effects of E2F1–cyclin E1–E2 circuit down regulation in hepatocellular carcinoma cells
12天前
已完结
Androgen synthesis in prostate cancer: do all roads lead to Rome?
15天前
已完结
Agonists for cytosolic bacterial receptor ALPK1 induce antitumour immunity
19天前
已完结
Probing the structure and function of polymerase θ helicase-like domain
21天前
已完结
Humanized mouse models: A valuable platform for preclinical evaluation of human cancer
22天前
已完结
Evaluation of a TGN1412 analogue using in vitro assays and two immune humanized mouse models
22天前
已完结
Discovery of Tetracyclic Derivatives as Highly Potent, Selective, and Bioavailable PKMYT1 Inhibitors for Cancer Therapy
25天前
已完结
皖公网安备34019202002308
